{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:07:11Z","timestamp":1762542431463,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.brachy.2015.04.010","type":"journal-article","created":{"date-parts":[[2015,6,14]],"date-time":"2015-06-14T02:56:59Z","timestamp":1434250619000},"page":"718-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling"],"prefix":"10.1016","volume":"14","author":[{"given":"Andrew W.","family":"Browne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savita V.","family":"Dandapani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Jennelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Stevanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Linn","family":"Murphree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2339-7090","authenticated-orcid":false,"given":"Thomas D.","family":"Kampp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvin A.","family":"Astrahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse L.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2015.04.010_bib1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18","volume":"119","author":"Diener-West","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2015.04.010_bib2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ophtha.2011.11.011","article-title":"Intraoperative ultrasonography-guided positioning of iodine 125 plaque brachytherapy in the treatment of choroidal melanoma","volume":"119","author":"Chang","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2015.04.010_bib3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.ijrobp.2004.09.062","article-title":"Improved treatment planning for COMS eye plaques","volume":"61","author":"Astrahan","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.04.010_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0360-3016(90)90077-W","article-title":"An interactive treatment planning system for ophthalmic plaque radiotherapy","volume":"18","author":"Astrahan","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.04.010_bib5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1118\/1.596585","article-title":"Optimization of 125I ophthalmic plaque brachytherapy","volume":"17","author":"Astrahan","year":"1990","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2015.04.010_bib6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0360-3016(97)00118-1","article-title":"Conformal episcleral plaque therapy","volume":"39","author":"Astrahan","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.04.010_bib7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1118\/1.597031","article-title":"Tumor localization using fundus view photography for episcleral plaque therapy","volume":"20","author":"Evans","year":"1993","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2015.04.010_bib8","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/jamaophthalmol.2013.4422","article-title":"Outcomes of choroidal melanomas treated with eye physics: A 20-year review","volume":"131","author":"Berry","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.brachy.2015.04.010_bib9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1259\/bjr\/76813976","article-title":"Dosimetric comparison of 106Ru and 125I plaques for treatment of shallow (<or=5 mm) choroidal melanoma lesions","volume":"81","author":"Wilkinson","year":"2008","journal-title":"Br J Radiol"},{"key":"10.1016\/j.brachy.2015.04.010_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.brachy.2012.01.012","article-title":"Tumor control, eye preservation, and visual outcomes of ruthenium plaque brachytherapy for choroidal melanoma","volume":"12","author":"Marconi","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.04.010_bib11","first-page":"1919","article-title":"Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: A mono-institutional experience","volume":"16","author":"Perri","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.brachy.2015.04.010_bib12","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1016\/j.prro.2013.08.004","article-title":"Disease control and toxicity outcomes using ruthenium eye plaque brachytherapy in the treatment of uveal melanoma","volume":"4","author":"Takiar","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2015.04.010_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.brachy.2014.04.002","article-title":"Ru plaque brachytherapy for uveal melanoma: Factors associated with local tumor recurrence","volume":"13","author":"Barker","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.04.010_bib14","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.brachy.2015.04.010_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2013.11.008","article-title":"The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma","volume":"13","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2015.04.010_bib16","first-page":"1219","article-title":"A patch source model for treatment planning of ruthenium ophthalmic applicators","volume":"30","author":"Astrahan","year":"2003","journal-title":"Am Assoc Phys Med"},{"key":"10.1016\/j.brachy.2015.04.010_bib17","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjophthalmol-2012-302490","article-title":"Local treatment failure after globe-conserving therapy for choroidal melanoma","volume":"97","author":"Chang","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.brachy.2015.04.010_bib18","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1590\/S0100-39842007000200008","article-title":"Preliminary results of ruthenium plaque brachytherapy in uveal melanoma: Uni-institutional experience","volume":"40","author":"Dias","year":"2007","journal-title":"Radiol Bras"},{"key":"10.1016\/j.brachy.2015.04.010_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02841860500468950","article-title":"Visual outcome, local tumour control, and eye preservation after 106Ru\/Rh brachytherapy for choroidal melanoma","volume":"45","author":"Isager","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.brachy.2015.04.010_bib20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ophtha.2004.11.038","article-title":"Ruthenium brachytherapy for uveal melanoma, 1979-2003: Survival and functional outcomes in the Swedish population","volume":"112","author":"Bergman","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.brachy.2015.04.010_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijrobp.2005.02.017","article-title":"Local tumor control after 106Ru brachytherapy of choroidal melanoma","volume":"63","author":"Damato","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2015.04.010_bib22","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.radonc.2010.03.023","article-title":"Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma","volume":"95","author":"Verschueren","year":"2010","journal-title":"Radiother Oncol"},{"year":"2014","series-title":"Nuclear wallet cards for radioactive nucleotides","author":"Tuli","key":"10.1016\/j.brachy.2015.04.010_bib23"},{"key":"10.1016\/j.brachy.2015.04.010_bib24","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/bjophthalmol-2014-305055","article-title":"High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome","volume":"98","author":"Fili","year":"2014","journal-title":"Br J Ophthalmol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472115004730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472115004730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:09:08Z","timestamp":1761530948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472115004730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1538472115004730"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2015.04.010","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2015.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}